Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Katie S McClendon, Daniel M Riche & Gabriel Ikponmosa Uwaifo. (2009) Orlistat: current status in clinical therapeutics. Expert Opinion on Drug Safety 8:6, pages 727-744.
Read now
Read now
L H Bösenberg & D G van Zyl. (2008) The mechanism of action of oral antidiabetic drugs: A review of recent literature. Journal of Endocrinology, Metabolism and Diabetes of South Africa 13:3, pages 80-88.
Read now
Read now
Articles from other publishers (22)
Kashif Rafiq, Majid Khan, Niaz Muhammed, Ajmal Khan, Najeeb Ur Rehman, Balqees Essa Mohammad Al-Yahyaei, Mohammed Khiat, Sobia Ahsan Halim, Zarbad Shah, Rene Csuk & Ahmed Al-Harrasi. (2021) New amino acid clubbed Schiff bases inhibit carbonic anhydrase II, α-glucosidase, and urease enzymes: in silico and in vitro. Medicinal Chemistry Research 30:3, pages 712-728.
Crossref
Crossref
T. Kocher, B. Holtfreter, A. Petersmann, P. Eickholz, T. Hoffmann, D. Kaner, T.S. Kim, J. Meyle, U. Schlagenhauf, S. Doering, M. Gravemeier, K. Prior, W. Rathmann, I. Harks, B. Ehmke & R. Koch. (2018) Effect of Periodontal Treatment on HbA1c among Patients with Prediabetes. Journal of Dental Research 98:2, pages 171-179.
Crossref
Crossref
Alok K. Gupta, Ajay Menon, Meghan Brashear & William D. Johnson. 2018. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome
15
32
.
Poobalan Naidoo, Jeffrey Wing & Virendra Rambiritch. (2016) Effect of Sitagliptin and Metformin on Prediabetes Progression to Type 2 Diabetes - A Randomized, Double-Blind, Double-Arm, Multicenter Clinical Trial: Protocol for the Sitagliptin and Metformin in PreDiabetes (SiMePreD) Study. JMIR Research Protocols 5:3, pages e145.
Crossref
Crossref
Susanne Fonville, Adrienne A.M. Zandbergen, Peter J. Koudstaal & Heleen M. den Hertog. (2014) Prediabetes in Patients with Stroke or Transient Ischemic Attack: Prevalence, Risk and Clinical Management. Cerebrovascular Diseases 37:6, pages 393-400.
Crossref
Crossref
A. Fontbonne. 2014. Diabétologie. Diabétologie
3
9
.
Eduardo Cabrera-Rode, Neraldo Orlandi, Yaneysi Padrón, Celeste Arranz, Raysa Olano, Mayra Machado, Arturo Hernández-Yero, Raúl Calderín & Emma Domínguez. (2013) Effect of Diamel in patients with metabolic syndrome: A randomized double-blind placebo-controlled study (Diamel对代谢综合征患者的影响：一项随机双盲安慰剂对照研究). Journal of Diabetes 5:2, pages 180-191.
Crossref
Crossref
J. Lindström, M. Peltonen, J. G. Eriksson, P. Ilanne-Parikka, S. Aunola, S. Keinänen-Kiukaanniemi, M. Uusitupa & J. Tuomilehto. (2012) Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56:2, pages 284-293.
Crossref
Crossref
Ike S. Okosun, Monique Davis-Smith & J. Paul Seale. (2012) Awareness of diabetes risks is associated with healthy lifestyle behavior in diabetes free American adults: Evidence from a nationally representative sample. Primary Care Diabetes 6:2, pages 87-94.
Crossref
Crossref
Alok K. Gupta, Ajay Menon, Meghan Brashear & William D. Johnson. 2012. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome
57
75
.
Jean-Louis Chiasson & Sophie Bernard. (2011) Reducing cardiovascular risk factors in patients with prediabetes. Diabetes Management 1:4, pages 423-438.
Crossref
Crossref
Omid Rad Pour & Samuel Dagogo-Jack. (2011) Prediabetes as a Therapeutic Target. Clinical Chemistry 57:2, pages 215-220.
Crossref
Crossref
Leopold Fezeu, Emma Fointama, George Ngufor, George Mbeh & Jean-Claude Mbanya. (2010) Diabetes awareness in general population in Cameroon. Diabetes Research and Clinical Practice 90:3, pages 312-318.
Crossref
Crossref
A. Fontbonne. 2010. Diabétologie. Diabétologie
3
10
.
Alan J. Garber. (2009) Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes. Diabetes Care 32:suppl_2, pages S184-S188.
Crossref
Crossref
James H. FlorySusan EllenbergPhilippe O. SzaparyBrian L. StromSean Hennessy. (2009) Antidiabetic Action of Bezafibrate in a Large Observational Database. Diabetes Care 32:4, pages 547-551.
Crossref
Crossref
George Kraus, Yi Yuan & Aaron Kempema. (2009) A Convenient Synthesis of Type A Procyanidins. Molecules 14:2, pages 807-815.
Crossref
Crossref
Mohammed A Al Shafaee, Sulaiman Al-Shukaili, Syed Gauher A Rizvi, Yahya Al Farsi, Mushtaq A Khan, Shyam S Ganguly, Mustafa Afifi & Samir Al Adawi. (2008) Knowledge and perceptions of diabetes in a semi-urban Omani population. BMC Public Health 8:1.
Crossref
Crossref
Saleh A. Aldasouqi & Ved V. Gossain. (2008)
Hemoglobin A
1c
: Past, present and future
. Annals of Saudi Medicine 28:6, pages 411-419.
Crossref
Crossref
E. Gonzlez Sarmiento, M.C. Hinojosa Mena-Bernal & L. Inglada Galiana. (2008) Diabetes mellitus tipo 1 y 2: etiopatogenia, formas de comienzo, manifestaciones cl?nicas, historia natural. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:17, pages 1091-1101.
Crossref
Crossref
Markolf Hanefeld, Frank Schaper & Carsta Koehler. (2008) Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance. Cardiovascular Drugs and Therapy 22:3, pages 225-231.
Crossref
Crossref
David C. Klonoff. (2008) Personalized Medicine for Diabetes. Journal of Diabetes Science and Technology 2:3, pages 335-341.
Crossref
Crossref